intramolecular cyclization. Compounds 1f-h were generated
from amino acids linked to the Rink Amide MBHA resin.
For these compounds the 2-amino group of the 2-aminoimi-
dazolone did not serve as the attachment point to the resin.
Despite the additional step of coupling this group to the resin,
the yields and purities of these compounds compare well
with those that are not substituted in this position. In general,
the isolated yields and purities of all entries are high,
demonstrating the efficiency of each step in the sequence.
To access unsaturated structures of the general type 2, we
initially attempted to add an aldehyde to the resin-bound
2
-aminoimidazolinone 7, generated from Fmoc-glycine.
a
Legend: (a) (i) Fmoc-NCS, CH
2 2
Cl , (ii) 20% piperidine in
DMF, (iii) MeI, DMF; (b) (i) HOBT, HBTU, NMM, DMF, (ii)
2
6
0% piperidine in DMF; (c) DMSO, 80 °C; (d) 95% aqueous TFA,
0 °C.
Although there are reports of solution-phase reactions that
accomplish a similar transformation, all of our efforts to
6
carry out this reaction on the solid phase failed.
To overcome this problem, an oxazolone was added to the
resin bound S-methyl isothiourea 4 as shown in Scheme 2.
heating (60 °C) was required to cleave the 2-aminoimida-
zolone from the resin with 95% aqueous trifluoroacetic acid.
5
Table 1 summarizes the yields and substrates used for this
reaction. Bulky substituents such as a tert-butyl group in the
R
4
position (compound 1a) are still able to complete the
Table 1. Synthesis of 2-Aminoimidazolones
a
Legend: (a) DMF, EtONa (2 equiv), 100 °C; (b) 95% aqueous
TFA, 60 °C.
The S-methyl isothiourea 4 was generated from Rink
Amide MBHA resin in a procedure identical with that
outlined in Scheme 1. Treatment of 4 with the oxazolone 9
(5) General procedure for the synthesis of 2-aminoimidazolones: Rink
Amide MBHA resin (0.5 g, 0.34 mmol) was placed into a plastic syringe,
and DMF (10 mL, 5 min, 3×) was added. The resin was treated with 20%
piperidine in DMF (10 mL, 20 min, 2×) and washed with DMF (10 mL,
3
0 s, 3×), MeOH (10 mL, 30 s, 3×), and CH2Cl2 (10 mL, 30 s, 3×). Fmoc-
NCS in CH2Cl2 (0.25 M, 10 mL, 2 h) was added to the resin followed by
CH2Cl2 (10 mL, 30 s, 3×) and DMF (10 mL, 30 s, 3×) washes. A mixture
of 20% piperidine in DMF (10 mL, 20 min, 2×) was added, the resin was
washed with DMF (10 mL, 30 s, 3×), and a DMF solution of CH3I (0.5
M, 7 mL, 1 h, 3×) was added. The resin was washed with DMF (10 mL,
3
0 s, 3×), 17 mL of a DMF solution of HOBT(0.1 M)/HBTU(0.1 M)/
NMM(0.2 M) was added followed by Fmoc-R-tert-butyl glycine (0.6 g, 5
equiv) (Table 1, compound 1a), and the resin was agitated for 4 h. The
resin was washed with DMF (10 mL, 30 s, 5×) and treated with 20%
piperidine in DMF (10 mL, 20 min, 2×), followed by a DMF wash (10
mL, 30 s, 5×). DMSO was added (10 mL), and the resin was heated at 80
°
C for 24 h. After it was cooled to room temperature, the resin was washed
a
Yields were determined using the loading level of the starting resin
with DMF (10 mL, 30 s, 3×), MeOH (10 mL, 30 s, 3×), and DCM (10
mL, 1 min, 5×). The resin was dried under nitrogen for 10 min and cleaved
with 95% aqueous TFA at 60 °C for 4 h. The cleavage eluant was collected,
and are based on isolated product.
1352
Org. Lett., Vol. 1, No. 9, 1999